top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights

Incyte Corp. to Acquire Escient Pharmaceuticals for $750M

Wilmington, DE, April 23, 2024 (RTTNews) -- Incyte Corp. (INCY) is buying Escient Pharmaceuticals and its assets for $750 million, plus any cash left over when the deal closes. This acquisition needs approval under the Hart-Scott-Rodino Act and some standard conditions. If everything goes as planned, the deal could be finished by the third quarter of 2024.


Read full article here.

Recent Posts

See All

Comments


Life Science Headlines
bottom of page